News International Sugar Journal

Genomatica focuses on developing biobased nylon intermediates [Registered]

The US biotech start-up Genomatic recently announced that major nylon intermediates – including hexamethylenediamine, caprolactam and adipic acid (HMD, CPL and ADA) – are the focus of its third publicly-disclosed development program. The company is developing complete process technologies for the biobased production of these intermediates, which it will then license to major firms in the nylon value chain. These three chemicals have a total market of over $18 billion annually. Genomatica has been building a comprehensive set of nylon program assets over the last few years. A number of the concepts described by Genomatica’s patent filings have been validated…

Login or sign up

Create an account

Lost your password?